Back to
Driehaus Capital Management LLC
CYTK
Showing 0 of 19 quarters
Position history for
Driehaus Capital Management LLC's holdings in Cytokinetics, Incorporated
No. Driehaus Capital Management exited its CYTK (Cytokinetics) position in Q1 2024. Its Q4 2023 13F listed 220,384 shares worth $18.4M. Driehaus Capital Management first reported CYTK in Q2 2019 and held it in 17 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.